Retraction: Berberine improves kidney function in diabetic mice via AMPK activation (PLoS ONE (2014) 9:11 (e113398) DOI: 10.1371/journal.pone.0113398);Berberine improves kidney function in diabetic mice via AMPK activation

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Zhao, Long ^a   Sun, Li Na ^a   Nie, Hui Bin ^a   Wang, Xue Ling ^a   Guan, Guang Ju ^a  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE; ADENYLATE KINASE; ALBUMIN; BERBERINE; NITROGEN; PROTEIN KINASE LKB1; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; THREONINE; UREA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CREATININE CLEARANCE; CULTURE MEDIUM; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GLOMERULOSCLEROSIS; GLOMERULUS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MESANGIUM CELL; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SECRETION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; GENE EXPRESSION REGULATION; KIDNEY FUNCTION TEST; METABOLISM; PHOSPHORYLATION;

ANIMALIA; MUS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BERBERINE; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; HUMANS; KIDNEY FUNCTION TESTS; MESANGIAL CELLS; MICE; OXIDATIVE STRESS; PHOSPHORYLATION; STREPTOZOCIN;

EID: 84919341507     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0190562     Document Type: Erratum

References (38)

1. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, et al. (2005) The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 28: 2130-2135.
2. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, et al. (2004) Nephropathy in diabetes. Diabetes Care 27 Suppl 1: S79-83.
3. Jha JC, Jandeleit-Dahm KA, Cooper ME (2014) New Insights Into the Use of Biomarkers of Diabetic Nephropathy. Adv Chronic Kidney Dis 21: 318-326.
4. Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57: 1446-1454.
5. Yin J, Zhang H, Ye J (2008) Traditional chinese medicine in treatment of metabolic syndrome. Endocr Metab Immune Disord Drug Targets 8: 99-111.
6. Liang KW, Ting CT, Yin SC, Chen YT, Lin SJ, et al. (2006) Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. Biochem Pharmacol 71: 806-817.
7. Cho BJ, Im EK, Kwon JH, Lee KH, Shin HJ, et al. (2005) Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells. Mol Cells 20: 429-434.
8. Li Z, Geng YN, Jiang JD, Kong WJ (2014) Antioxidant and Anti-Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus. Evid Based Complement Alternat Med 2014: 289264.
9. Wang S, Xu J, Song P, Viollet B, Zou MH (2009) In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I. Diabetes 58: 1893-1901.
10. Liang KW, Yin SC, Ting CT, Lin SJ, Hsueh CM, et al. (2008) Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells. Eur J Pharmacol 590: 343-354.
11. Chang W, Zhang M, Li J, Meng Z, Wei S, et al. (2013) Berberine improves insulin resistance in cardiomyocytes via activation of 59-adenosine monophosphate-activated protein kinase. Metabolism 62: 1159-1167.
12. Lv X, Yu X, Wang Y, Wang F, Li H, et al. (2012) Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression. PLoS One 7: e47351.
13. Fan LX, Liu CM, Gao AH, Zhou YB, Li J (2013) Berberine combined with 2-deoxy-d-glucose synergistically enhances cancer cell proliferation inhibition via energy depletion and unfolded protein response disruption. Biochim Biophys Acta 1830: 5175-5183.
14. Shen N, Huan Y, Shen ZF (2012) Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic beta-cell. Eur J Pharmacol 694: 120-126.
15. Cao S, Zhou Y, Xu P, Wang Y, Yan J, et al. (2013) Berberine metabolites exhibit triglyceride-lowering effects via activation of AMP-activated protein kinase in Hep G2 cells. J Ethnopharmacol 149: 576-582.
16. Mo C, Wang L, Zhang J, Numazawa S, Tang H, et al. (2014) The crosstalk between Nrf2 and AMPK signal pathways is important for the antiinflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid Redox Signal 20: 574-588.
17. Jeong HW, Hsu KC, Lee JW, Ham M, Huh JY, et al. (2009) Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab 296: E955-964.
18. Zhou L, Wang X, Yang Y, Wu L, Li F, et al. (2011) Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes. Biochim Biophys Acta 1812: 527-535.
19. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Flamez D, et al. (2003) Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem Soc Trans 31: 216-219.
20. Wang S, Peng Q, Zhang J, Liu L (2008) Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain. Cardiovasc Res 80: 255-262.
21. Liao J, Soltani Z, Ebenezer P, Isidro-Carrion AA, Zhang R, et al. (2010) Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker rats. Nephron Exp Nephrol 114: e61-68.
22. Wang S, Xu J, Song P, Wu Y, Zhang J, et al. (2008) Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure. Hypertension 52: 484-490.
23. Fernandes DC, Wosniak J Jr., Pescatore LA, Bertoline MA, Liberman M, et al. (2007) Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems. Am J Physiol Cell Physiol 292: C413-422.
24. Wang S, Liang B, Viollet B, Zou MH (2011) Inhibition of the AMP-activated protein kinase-alpha2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice. Hypertension 57: 1010-1017.
25. Wang S, Zhang M, Liang B, Xu J, Xie Z, et al. (2010) AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res 106: 1117-1128.
26. Shen Y, Honma N, Kobayashi K, Jia LN, Hosono T, et al. (2014) Cinnamon extract enhances glucose uptake in 3T3-L1 adipocytes and C2C12 myocytes by inducing LKB1-AMP-activated protein kinase signaling. PLoS One 9: e87894.
27. Homolya L, Fu D, Sengupta P, Jarnik M, Gillet JP, et al. (2014) LKB1/AMPK and PKA control ABCB11 trafficking and polarization in hepatocytes. PLoS One 9: e91921.
28. Wang S, Zhang C, Zhang M, Liang B, Zhu H, et al. (2012) Activation of AMP-activated protein kinase alpha2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo. Nat Med 18: 902-910.
29. Zhao HL, Sui Y, Qiao CF, Yip KY, Leung RK, et al. (2012) Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression. Diabetes 61: 933-943.
30. Yang Y, Ni W, Cai M, Tang L, Wei W (2014) The renoprotective effects of berberine via the EP4-Gas-cAMP signaling pathway in different stages of diabetes in rats. J Recept Signal Transduct Res 22: 1-11.
31. Tang LQ, Liu S, Zhang ST, Zhu LN, Wang FL (2014) Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy. Mol Biol Rep 41: 3339-3347.
32. Chatuphonprasert W, Lao-Ong T, Jarukamjorn K (2013) Improvement of superoxide dismutase and catalase in streptozotocin-nicotinamide-induced type 2-diabetes in mice by berberine and glibenclamide. Pharm Biol.
33. Wan X, Chen X, Liu L, Zhao Y, Huang WJ, et al. (2013) Berberine ameliorates chronic kidney injury caused by atherosclerotic renovascular disease through the suppression of NFkappaB signaling pathway in rats. PLoS One 8: e59794.
34. Han Y, Wang Q, Song P, Zhu Y, Zou MH (2010) Redox regulation of the AMP-activated protein kinase. PLoS One 5: e15420.
35. Wang Q, Zhang M, Liang B, Shirwany N, Zhu Y, et al. (2011) Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2. PLoS One 6: e25436.
36. Qi Z, Fujita H, Jin J, Davis LS, Wang Y, et al. (2005) Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes 54: 2628-2637.
37. Zhang M, Liu M, Xiong M, Gong J, Tan X (2012) Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy. J Ethnopharmacol 141: 111-118.
38. Dugan LL, You YH, Ali SS, Diamond-Stanic M, Miyamoto S, et al. (2013) AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J Clin Invest 123: 4888-4899.